ARE/SUZ12 dual specifically-regulated adenoviral TK/GCV system for CML blast crisis cells

BACKGROUND: Treatment of blast phase chronic myeloid leukemia (BP-CML) remains a challenge, and the median survival is less than 6 months. Because effective treatments are lacking, we studied tight targeting of blast crisis CML cells using adenoviral (Ad) vectors expressing a HSV-TK system under dua...

Descripción completa

Detalles Bibliográficos
Autores principales: Zu, Bailing, Shi, Yi, Xu, Min, You, Guoling, Huang, Zhenglan, Gao, Miao, Feng, Wenli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456766/
https://www.ncbi.nlm.nih.gov/pubmed/26017281
http://dx.doi.org/10.1186/s13046-015-0139-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456766/
https://www.ncbi.nlm.nih.gov/pubmed/26017281
http://dx.doi.org/10.1186/s13046-015-0139-4

Ejemplares similares